Aptevo Therapeutics Surges Over 46% After Hours On Breakthrough AML Treatment Results - Aptevo Therapeutics (NASDAQ:APVO)

Aptevo Therapeutics Surges Over 46% After Hours On Breakthrough AML Treatment Results - Aptevo Therapeutics (NASDAQ:APVO)

Aptevo Therapeutics Inc. (NASDAQ:APVO) jumped 46.10% to $2.06 during after-hours trading on Wednesday following breakthrough clinical results demonstrating its drug’s potential to redefine frontline AML treatment. Check out the current price of APVO stock here. Clinical Trial Delivers Perfect Remission Rate The biotech company from Seattle reported that all patients in Cohort 3 of its Phase 1b/2 RAINIER trial went into complete remission. The tr…